Explore how BCs are supported through complex drug approvals and ensuring patients have access to prescribed medications.
Biologics Coordinators of Dermatology
Latest Content
Advertisement
Advertisement
Trending on Dermatology Times
1
Dermatology Times Monthly FDA and Pipeline Review: October 2026
2
Phase 3 Trial Supports Risankizumab for Pediatric Psoriasis
3
Clinicians Explore Type 2 Inflammation Across Dermatologic Diseases
4
Brepocitinib Clears Skin in 69% of Cutaneous Sarcoidosis Patients
5